Abstract:Gene transcription is a highly regulated process, and deregulation of transcription factors activity underlies numerous pathologies including cancer. Albeit near four decades of studies have established that the E2F pathway is a core transcriptional network that govern cell division in multi-cellular organisms , the molecular mechanisms that underlie the functions of E2F transcription factors remain incompletely understood. FOXK1 and FOXK2 transcription factors have recently emerged as important regulators of cell metabolism, autophagy and cell differentiation . While both FOXK1 and FOXK2 interact with the histone H2AK119ub deubiquitinase BAP1 and possess many overlapping functions in normal biology, their specific functions as well as deregulation of their transcriptional activity in cancer is less clear and sometimes contradictory . Here, we show that elevated expression of FOXK1, but not FOXK2, in primary normal cells promotes transcription of E2F target genes associated with increased proliferation and delayed entry into cellular senescence. FOXK1 expressing cells are highly prone to cellular transformation revealing important oncogenic properties of FOXK1 in tumor initiation. High expression of FOXK1 in patient tumors is also highly correlated with E2F gene expression. Mechanistically, we demonstrate that FOXK1, but not FOXK2, is specifically modified by O-GlcNAcylation. FOXK1 O-GlcNAcylation is modulated during the cell cycle with the highest levels occurring during the time of E2F pathway activation at G1/S. Moreover, loss of FOXK1 O-GlcNAcylation impairs FOXK1 ability to promote cell proliferation, cellular transformation and tumor growth. Mechanistically, expression of FOXK1 O-GlcNAcylation-defective mutants results in reduced recruitment of BAP1 to gene regulatory regions. This event is associated with a concomitant increase in the levels of histone H2AK119ub and a decrease in the levels of H3K4me1, resulting in a transcriptional repressive chromatin environment. Our results define an essential role of O-GlcNAcylation in modulating the functions of FOXK1 in controlling the cell cycle of normal and cancer cells through orchestration of the E2F pathway.

Triple Layer Control: Phosphorylation, Acetylation and Ubiquitination of FOXO Proteins

Dynamic FoxO transcription factors

mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity

Prolyl Hydroxylation by EglN2 Destabilizes FOXO3a by Blocking Its Interaction with the USP9x Deubiquitinase

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

FOXN Transcription Factors: Regulation and Significant Role in Cancer

Akt, FoxO and regulation of apoptosis

IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function

FoxO family members in cancer

The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

O-GlcNAcylation of FOXK1 orchestrates the E2F pathway and promotes oncogenesis

FOXO3 Induces FOXO1-dependent Autophagy by Activating the AKT1 Signaling Pathway.

Regulatory Function of Phosphorylation and Ubiquitination on The TORC1 Signaling Pathway

FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance

Applications of Post-Translational Modifications of FoxO Family Proteins in Biological Functions.

Mitochondria and Forkhead Box Protein O 3A

FOXO Signaling Pathways as Therapeutic Targets in Cancer

Molecular and Cellular Pathobiology FoxO Transcription Factors Promote AKT Ser 473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI 3 K – AKT Pathway

FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders

Mechanisms Controlling the Anti-Neoplastic Functions of FoxO Proteins.